Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$291K Sell
772
-135
-15% -$41.9K ﹤0.01% 1197
2026
Q1
$227K Buy
+907
New +$227K ﹤0.01% 1255
2020
Q4
Sell
-285
Closed -$16K 1879
2020
Q3
$16K Sell
285
-26
-8% -$1.4K ﹤0.01% 1695
2020
Q2
$15K Sell
311
-30
-9% -$1.33K ﹤0.01% 1712
2020
Q1
$22K Hold
341
﹤0.01% 2041
2019
Q4
$22K Buy
341
+105
+44% +$6.98K ﹤0.01% 2041
2019
Q3
$15K Buy
236
+148
+168% +$9.61K ﹤0.01% 2182
2019
Q2
$5K Hold
88
﹤0.01% 2636
2019
Q1
$5K Hold
88
﹤0.01% 2615
2018
Q4
$5K Buy
+88
New +$5.83K ﹤0.01% 2544
2017
Q3
Sell
-64
Closed -$4K 2797
2017
Q2
$4K Hold
64
﹤0.01% 2342
2017
Q1
$4K Buy
+64
New +$4.24K ﹤0.01% 2342
2015
Q3
Sell
-58
Closed -$3K 2785
2015
Q2
$3K Buy
+58
New +$3.65K ﹤0.01% 2354

Other funds holding NPO

Glenmede Trust's NPO Position: Q2 2026 in Review

Glenmede Trust reduced its Enpro (NPO) stake by 15% in Q2 2026, selling an estimated $41.9K and leaving 772 shares worth $291K. The position accounts for ﹤0.01% of the portfolio, ranked #1197.

Glenmede Trust first reported a position in NPO in Q2 2015 and has held it in 13 quarters since. 408 funds tracked by Wall St. Rank hold NPO as of Q2 2026.

  • Glenmede Trust held 772 shares of Enpro worth $291K as of Q2 2026.
  • Glenmede Trust sold 135 Enpro shares in Q2 2026, an estimated $41.9K.
  • Enpro made up ﹤0.01% of Glenmede Trust's portfolio in Q2 2026, its #1197 holding.
  • Glenmede Trust first reported a position in Enpro in Q2 2015 and has held it in 13 quarters since.
  • 408 funds tracked by Wall St. Rank held Enpro as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.